{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:40:33Z","timestamp":1792424433633,"version":"4.5.0"},"reference-count":67,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Attention-deficit\/hyperactivity disorder (ADHD) is associated with adverse life outcomes and increased mortality. Clarifying the magnitude of mortality risks using international data and the potential association between medication and mortality is essential to inform clinical care and motivate public health strategies to address mortality.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n To examine the association between ADHD and all-cause and cause-specific mortality and to assess whether mortality risk differs according to ADHD medication use.<\/jats:p>\n <\/jats:sec>\n \n Data Sources<\/jats:title>\n A comprehensive search of PubMed, Web of Science, PsycINFO, EMBASE, MEDLINE, and CINAHL was conducted from database inception to July 8, 2025.<\/jats:p>\n <\/jats:sec>\n \n Study Selection<\/jats:title>\n Eligible studies included quantitative research across all age groups reporting all-cause and\/or cause-specific mortality in individuals with ADHD, defined via diagnostic criteria, self-identification, trait measures, or ADHD polygenic risk scores. Exclusion criteria were nonoriginal research, qualitative studies, non\u2013peer-reviewed publications, and studies not reporting mortality outcomes.<\/jats:p>\n <\/jats:sec>\n \n Data Extraction and Synthesis<\/jats:title>\n Data extraction was conducted independently by 2 reviewers. Study quality was assessed by 1 reviewer. Summary data were extracted from published reports, and pooled hazard ratios (HRs) were calculated using random-effects model meta-analysis.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcomes were all-cause mortality and cause-specific mortality (suicide, unintentional or intentional injury, and natural causes), measured using HRs with 95% CIs.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Nineteen studies including 15\u202f920\u202f970 participants (36.1% female) were included. ADHD was associated with increased all-cause mortality (HR, 1.71; 95% CI, 1.31-2.24;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). Significant associations were also observed for suicide (HR, 1.89; 95% CI, 1.21-2.95;\n P<\/jats:italic>\n \u2009=\u2009.005), unintentional or intentional injury (HR, 1.55; 95% CI, 1.22-2.00;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001), and natural-cause mortality (HR, 1.27; 95% CI, 1.16-1.38;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). ADHD medication use in people with ADHD was associated with reduced all-cause mortality (HR, 0.75; 95% CI, 0.64-0.87;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). Substantial heterogeneity was observed across studies.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this systematic review and meta-analysis of ADHD and mortality, ADHD was associated with increased mortality across multiple causes; and ADHD medication was associated with a decreased all-cause mortality risk, underscoring the importance of timely diagnosis and treatment. However, the heterogeneity observed across studies highlights the need for standardized methods and improved control of confounding factors to better characterize mortality risk among individuals with ADHD.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.39448","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:00:38Z","timestamp":1792422038000},"page":"e2639448","source":"Crossref","is-referenced-by-count":0,"title":["Mortality Among People With Attention-Deficit\/Hyperactivity Disorder"],"prefix":"10.1001","volume":"9","author":[{"given":"Lucy","family":"Corrigan","sequence":"first","affiliation":[{"name":"Department of Psychology, University of Liverpool, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Heywood","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Liverpool, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin R.","family":"Stewart","sequence":"additional","affiliation":[{"name":"Social, Genetic, and Developmental Psychiatry Centre, Kings College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"O\u2019Nions","sequence":"additional","affiliation":[{"name":"Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, United Kingdom"},{"name":"Clinical, Educational, and Health Psychology, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Shelford","sequence":"additional","affiliation":[{"name":"ADHD UK, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Stott","sequence":"additional","affiliation":[{"name":"Clinical, Educational, and Health Psychology, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"John","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Liverpool, Liverpool, United Kingdom"},{"name":"Clinical, Educational, and Health Psychology, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"issue":"1","key":"zoi261071r2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-024-00495-0","article-title":"Attention-deficit\/hyperactivity disorder.","volume":"10","author":"Faraone","year":"2024","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"zoi261071r3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/educsci13010037","article-title":"Schooling and occupational outcomes in adults with ADHD: predictors of success and support strategies for effective learning.","volume":"13","author":"Varrasi","year":"2022","journal-title":"Educ Sci"},{"issue":"10","key":"zoi261071r4","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00787-018-1217-x","article-title":"Association of ADHD medications with the risk of cardiovascular diseases: a meta-analysis.","volume":"28","author":"Liu","year":"2019","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"5","key":"zoi261071r5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1192\/bjp.2024.199","article-title":"Life expectancy and years of life lost for adults with diagnosed ADHD in the UK: matched cohort study.","volume":"226","author":"O\u2019Nions","year":"2025","journal-title":"Br J Psychiatry"},{"key":"zoi261071r6","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2025.1597559","article-title":"Adult ADHD and comorbid anxiety and depressive disorders: a review of etiology and treatment.","volume":"16","author":"Fu","year":"2025","journal-title":"Front Psychiatry"},{"key":"zoi261071r7","first-page":"36","article-title":"The function of reward sensitivity and temporal discounting in the relationship between risk and ADHD in adults.","volume":"46","author":"Taylor","year":"2017","journal-title":"N Z J Psychol"},{"issue":"758","key":"zoi261071r8","doi-asserted-by":"publisher","first-page":"e586","DOI":"10.3399\/BJGP.2024.0755","article-title":"Improving healthcare information for young people with ADHD in general practice: a qualitative study.","volume":"75","author":"Price","year":"2025","journal-title":"Br J Gen Pract"},{"issue":"3","key":"zoi261071r9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/wps.21020","article-title":"Attention-deficit\/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population-based cohort study.","volume":"21","author":"Li","year":"2022","journal-title":"World Psychiatry"},{"key":"zoi261071r10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2023.105076","article-title":"The association between type 2 diabetes and attention- deficit\/hyperactivity disorder: a systematic review, meta-analysis, and population-based sibling study.","volume":"147","author":"Garcia-Argibay","year":"2023","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"zoi261071r11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1586\/14737175.8.4.657","article-title":"Co-occurrence of ADHD and autism spectrum disorders: phenomenology and treatment.","volume":"8","author":"Reiersen","year":"2008","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"zoi261071r12","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2021.6401","article-title":"Mortality in persons with autism spectrum disorder or attention-deficit\/hyperactivity disorder.","volume":"176","author":"Catal\u00e1-L\u00f3pez","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"12","key":"zoi261071r13","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S2352-4642(23)00226-2","article-title":"Prospective associations between ADHD symptoms and physical conditions from early childhood to adolescence: a population-based longitudinal study.","volume":"7","author":"Gal\u00e8ra","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"issue":"6","key":"zoi261071r14","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2024.777","article-title":"Risk of physical health comorbidities in autistic adults: clinical nested cross-sectional study.","volume":"10","author":"Hunt","year":"2024","journal-title":"BJPsych Open"},{"issue":"20","key":"zoi261071r15","doi-asserted-by":"publisher","first-page":"7338","DOI":"10.3390\/jcm14207338","article-title":"Global trends in ADHD medication use: multiple contexts and rising concerns\u2014a narrative review.","volume":"14","author":"Rzeszutek","year":"2025","journal-title":"J Clin Med"},{"key":"zoi261071r17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-083658","article-title":"ADHD drug treatment and risk of suicidal behaviours, substance misuse, accidental injuries, transport accidents, and criminality: emulation of target trials.","volume":"390","author":"Zhang","year":"2025","journal-title":"BMJ"},{"issue":"71","key":"zoi261071r18","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"zoi261071r19","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2024.1786","article-title":"Prevalence of attention-deficit hyperactivity disorder (ADHD): systematic review and meta-analysis.","volume":"67","author":"Popit","year":"2024","journal-title":"Eur Psychiatry"},{"key":"zoi261071r22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package.","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"issue":"3","key":"zoi261071r23","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s00787-024-02511-w","article-title":"Longitudinal study on all-cause and suicide mortality among individuals with ADHD.","volume":"34","author":"Jeng","year":"2025","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"1","key":"zoi261071r24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12888-022-03967-3","article-title":"Mortality in individuals with childhood ADHD or subthreshold symptoms - a prospective perinatal risk cohort study over 40 years.","volume":"22","author":"Schiavone","year":"2022","journal-title":"BMC Psychiatry"},{"issue":"1","key":"zoi261071r25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12916-022-02279-3","article-title":"High polygenic predisposition for ADHD and a greater risk of all-cause mortality: a large population-based longitudinal study.","volume":"20","author":"Ajnakina","year":"2022","journal-title":"BMC Med"},{"issue":"8","key":"zoi261071r26","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.8714","article-title":"Attention-deficit\/hyperactivity disorder and mortality risk in Taiwan.","volume":"2","author":"Chen","year":"2019","journal-title":"JAMA Netw Open"},{"key":"zoi261071r27","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/jamapsychiatry.2019.1944","article-title":"Association of psychiatric comorbidity with the risk of premature death among children and adults with ADHD.","volume":"76","author":"Sun","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"9983","key":"zoi261071r28","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/S0140-6736(14)61684-6","article-title":"Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study.","volume":"385","author":"Dalsgaard","year":"2015","journal-title":"Lancet"},{"key":"zoi261071r29","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.1903","article-title":"Morbidities and mortality of diagnosed ADHD over the youth lifespan: a population-based retrospective cohort study.","volume":"31","author":"Diallo","year":"2022","journal-title":"Int J Methods Psychiatr Res"},{"key":"zoi261071r30","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1192\/bjp.2019.128","article-title":"Suicidal behaviour among persons with ADHD.","volume":"215","author":"Fitzgerald","year":"2019","journal-title":"Br J Psychiatry"},{"key":"zoi261071r31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1192\/bjp.2020.129","article-title":"Methylphenidate and mortality in children with ADHD: population-based cohort study.","volume":"220","author":"Chen","year":"2020","journal-title":"Br J Psychiatry"},{"issue":"1","key":"zoi261071r32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41398-024-02825-y","article-title":"ADHD medications use and risk of mortality and unintentional injuries: a population-based cohort study.","volume":"14","author":"Vasiliadis","year":"2024","journal-title":"Transl Psychiatry"},{"issue":"10","key":"zoi261071r33","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1001\/jama.2024.0851","article-title":"ADHD pharmacotherapy and mortality in individuals with ADHD.","volume":"331","author":"Li","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"zoi261071r34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/19485565.2021.2020618","article-title":"Attention deficit hyperactivity disorder and the age pattern of adult mortality.","volume":"67","author":"London","year":"2022","journal-title":"Biodemography Soc Biol"},{"issue":"4","key":"zoi261071r35","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1542\/peds.2012-2354","article-title":"Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study.","volume":"131","author":"Barbaresi","year":"2013","journal-title":"Pediatrics"},{"key":"zoi261071r36","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1001\/jamapsychiatry.2014.363","article-title":"Common etiological factors of ADHD and suicidal behavior.","volume":"71","author":"Ljung","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"zoi261071r37","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1176\/appi.ps.201800346","article-title":"Diagnosed mental health conditions and risk of suicide mortality.","volume":"70","author":"Yeh","year":"2019","journal-title":"Psychiatr Serv"},{"key":"zoi261071r38","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.116309","article-title":"Association between stimulant and non-stimulant ADHD medications and completed suicide: a population-based nested case-control study.","volume":"344","author":"Vasiliadis","year":"2025","journal-title":"Psychiatry Res"},{"key":"zoi261071r39","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.brainresbull.2022.07.005","article-title":"Treatment with stimulants and the risk of COVID-19 complications in adults with ADHD.","volume":"187","author":"Tuan","year":"2022","journal-title":"Brain Res Bull"},{"issue":"1","key":"zoi261071r40","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2023.643","article-title":"Stimulant medication and suicide mortality in attention-deficit hyperactivity disorder.","volume":"10","author":"Rice","year":"2024","journal-title":"BJPsych Open"},{"key":"zoi261071r41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2021.10.020","article-title":"Generalized anxiety disorder among adults with attention deficit hyperactivity disorder.","volume":"299","author":"Fuller-Thomson","year":"2021","journal-title":"J Affect Disord"},{"issue":"10","key":"zoi261071r42","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/0145-2134(96)00084-1","article-title":"Psychiatric comorbidity in childhood post traumatic stress disorder.","volume":"20","author":"Famularo","year":"1996","journal-title":"Child Abuse Negl"},{"key":"zoi261071r43","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.eurpsy.2013.06.004","article-title":"Association between ADHD in childhood and schizophrenia in adulthood.","volume":"29","author":"Dalsgaard","year":"2014","journal-title":"Eur Psychiatry"},{"issue":"1","key":"zoi261071r44","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/1087054712446171","article-title":"Alcohol and substance use history among ADHD adults: the relationship with persistent and remitting symptoms, personality, employment, and history of service use.","volume":"18","author":"Huntley","year":"2014","journal-title":"J Atten Disord"},{"key":"zoi261071r45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12402-012-0085-3","article-title":"Stigma in ADHD.","volume":"4","author":"Mueller","year":"2012","journal-title":"Atten Defic Hyperact Disord"},{"issue":"4","key":"zoi261071r46","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s44220-026-00600-0","article-title":"Childhood ADHD traits, societal exclusion and midlife psychological distress.","volume":"4","author":"John","year":"2026","journal-title":"Nat Ment Health"},{"issue":"3","key":"zoi261071r47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s12402-014-0150-1","article-title":"Adult ADHD and suicide.","volume":"6","author":"Furczyk","year":"2014","journal-title":"Atten Defic Hyperact Disord"},{"issue":"2","key":"zoi261071r48","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1177\/1087054709360494","article-title":"Decision making in adults with ADHD.","volume":"16","author":"M\u00e4ntyl\u00e4","year":"2012","journal-title":"J Atten Disord"},{"issue":"6","key":"zoi261071r49","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s11920-001-0044-8","article-title":"Attention deficit hyperactivity disorder (ADHD) and substance use disorders.","volume":"3","author":"Wilson","year":"2001","journal-title":"Curr Psychiatry Rep"},{"key":"zoi261071r50","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1001\/jamapsychiatry.2013.4174","article-title":"Serious transport accidents in adults with ADHD and the effect of medication.","volume":"71","author":"Chang","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"zoi261071r51","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1177\/10870547231158386","article-title":"Injury risk and disparities among children with ADHD.","volume":"27","author":"Shen","year":"2023","journal-title":"J Atten Disord"},{"issue":"11","key":"zoi261071r52","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1177\/1087054716633857","article-title":"Factors associated with accidental injuries in children with ADHD.","volume":"23","author":"Connolly","year":"2019","journal-title":"J Atten Disord"},{"key":"zoi261071r53","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.54802","article-title":"ADHD traits in childhood and physical health in midlife.","volume":"9","author":"Stott","year":"2026","journal-title":"JAMA Netw Open"},{"key":"zoi261071r54","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1343314","article-title":"The impacts associated with having ADHD: an umbrella review.","volume":"15","author":"French","year":"2024","journal-title":"Front Psychiatry"},{"key":"zoi261071r55","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.eurpsy.2017.07.002","article-title":"Stress, ADHD symptoms and tobacco smoking.","volume":"45","author":"Gal\u00e9ra","year":"2017","journal-title":"Eur Psychiatry"},{"issue":"1","key":"zoi261071r57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12402-014-0151-0","article-title":"Associations of sleep disturbance with ADHD: implications for treatment.","volume":"7","author":"Hvolby","year":"2015","journal-title":"Atten Defic Hyperact Disord"},{"issue":"6","key":"zoi261071r58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128248","article-title":"Socioeconomic associations with ADHD.","volume":"10","author":"Russell","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"zoi261071r59","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1177\/1087054720972790","article-title":"Examining the educational gap for children with ADHD and subthreshold.","volume":"26","author":"Zendarski","year":"2022","journal-title":"J Atten Disord"},{"issue":"8","key":"zoi261071r60","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jaac.2019.06.010","article-title":"Attention-deficit\/hyperactivity disorder medication and unintentional injuries in children and adolescents.","volume":"59","author":"Ghirardi","year":"2020","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"zoi261071r61","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.biopsych.2016.02.018","article-title":"ADHD medication and risk for depression.","volume":"80","author":"Chang","year":"2016","journal-title":"Biol Psychiatry"},{"issue":"8","key":"zoi261071r62","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/jcpp.12164","article-title":"Stimulant ADHD medication and risk for substance abuse.","volume":"55","author":"Chang","year":"2014","journal-title":"J Child Psychol Psychiatry"},{"key":"zoi261071r63","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1055\/s-0035-1557417","article-title":"Efficacy and tolerability of ADHD medications in clinical practice.","volume":"6","author":"Miller-Horn","year":"2015","journal-title":"J Pediatr Neurol"},{"key":"zoi261071r64","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/1087054706292165","article-title":"Medication adherence in adults with ADHD.","volume":"10","author":"Safren","year":"2007","journal-title":"J Atten Disord"},{"issue":"1","key":"zoi261071r65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2022.103205","article-title":"Gender-based differences in prevalence and effects of ADHD in adults: a systematic review.","volume":"75","author":"Faheem","year":"2022","journal-title":"Asian J Psychiatr"},{"issue":"3","key":"zoi261071r66","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1080\/13811118.2020.1856258","article-title":"The dark side of ADHD: factors associated with suicide attempts among those with ADHD in a national representative Canadian sample.","volume":"26","author":"Fuller-Thomson","year":"2022","journal-title":"Arch Suicide Res"},{"issue":"4","key":"zoi261071r67","doi-asserted-by":"publisher","DOI":"10.1002\/jcv2.12169","article-title":"Is there evidence of a causal link between childhood maltreatment and attention deficit\/hyperactivity disorder? a systematic review of prospective longitudinal studies using the Bradford-Hill criteria.","volume":"3","author":"Bali","year":"2023","journal-title":"JCPP Adv"},{"key":"zoi261071r56","first-page":"14","volume-title":"Diet Quality and Lifestyle Factors in ADHD: A Systematic Review and Meta-Analysis","author":"Papanastasiou","year":"2021"},{"key":"zoi261071r1","unstructured":"What is ADHD - about ADHD. ADHD UK. Published 2024. Accessed April 13, 2026. https:\/\/adhduk.co.uk\/about-adhd\/"},{"key":"zoi261071r16","unstructured":"Marsh? S, Aguilar Garc\u00eda? C. Record numbers in England taking ADHD medication, NHS data shows. The Guardian. Published July 26, 2024. Accessed April 13, 2026. https:\/\/www.theguardian.com\/society\/article\/2024\/jul\/26\/record-numbers-in-england-taking-adhd-medication-nhs-data-shows"},{"key":"zoi261071r20","unstructured":"Wells? G, Shea? B, O\u2019Connell? D, . Newcastle-Ottawa Scale (NOS). Published 2025. Accessed April 13, 2026. https:\/\/ohri.ca\/en\/who-we-are\/core-facilities-and-platforms\/ottawa-methods-centre\/newcastle-ottawa-scale"},{"key":"zoi261071r21","unstructured":"Lee? S. Understanding I-squared in meta-analysis: an essential practical guide. Published 2025. Accessed April 13, 2026. https:\/\/www.numberanalytics.com\/blog\/understanding-i-squared-meta-analysis-guide"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2855472\/corrigan_2026_oi_261071_1791821834.47107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:00:42Z","timestamp":1792422042000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2855472"}},"subtitle":["A Systematic Review and Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":67,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.39448","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,19]]}}}